Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8659631bf38b3a590c0d3edc265492c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D503-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D503-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-52 |
filingDate |
1979-03-29^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c3261a91315b2a9ca68d7658d7c44a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc0f280fdf7aabcc6d7440cf0a9d1ef6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89e71d3e2578001eb1716c12c4bad09e |
publicationDate |
1979-10-31^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0005014-A1 |
titleOfInvention |
Clavulanic acid derivatives, preparation and compositions |
abstract |
This invention provides the β-lactamase inhibitory compounds of the formula (II):n ana esters and acia addition salts of esters thereof wherein R 1 is an optionally substituted aromatic monocyclic or bicyclic heterocyclic group bonded via a carbon atom and R; is a group CH 2 R 1 , a hydrogen atom, a C 1-6 alkyl or hydroxyai- kyl group, an optionally substituted benzyl group, or a group of the sub-formula (a):n where R a is a C 1-3 alkyl group, and R b and R c are mdepen- dently hydrogen, C 1-3 alkyl or phenyl. n The invention also relates to processes for their preparation and pharmaceutical compositions containing them. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0009302-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0046349-A1 |
priorityDate |
1978-04-22^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |